PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Victims

Food and Healthcare Press Releases Thursday September 20, 2018 11:53
SINGAPORE and LONDON--20 Sep--PRNewswire/InfoQuest
  • Anbu Kochi joins hands with PULSUS Group in support of Kerala Flood Victims

In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group took initiative to extend a helping hand in donating clothes, food items, medicines, sanitation, hygiene products including edibles (baby food, ORS packets/electrolytes, rusk, biscuits), and non-edibles (anti-septic lotion, bleaching powder/lime powder, baby diapers, adult diapers, sanitary napkins, toothpaste, tooth brushes, body soap, washing soap, clothes old/new, water cans, candles and match boxes). PULSUS Group and Anbu Kochi are collecting daily essentials and other relief materials to help Kerala flood victims. PULSUS Group and Anbu Kochi stand for Kerala in helping the flood victims with necessities and donations.

In addition, all the employees at PULSUS Group have generously raised funds for the cause. Dr. Srinubabu Gedela, CEO, Pulsus & Omics International, addressing the issue has said, "What Kerala has experienced today is unparalleled by any of the disasters that the state had suffered in recent times. We take social responsibility to stand by them. Rebuilding the state can take years to come. Every rupee and contribution donated goes towards the wellbeing and uplifting of the state. Our thoughts and prayers are with flood relief victims, displaced, homeless families and the needs of the hour require our call of action to address their immediate needs to provide shelter, livelihood, and non-food items."

About PULSUS Group: PULSUS Group is an internationally renowned peer-review publisher and conferences organizer operational since 1984. Headquartered at Singapore, PULSUS Group has its offices in London (UK), Ontario (Canada) and Chennai, Gurgaon, Hyderabad (India). Endorsed by the medical associations and scientific societies, PULSUS promotes peer reviewed medical journals in association with international medical associations and scientific societies. PULSUS organizes 500+ global meetings per year across the world, enables physicians and industry professionals to convene together and form conclusive strategies towards advanced therapeutics and treatment aspects. PULSUS Group strives to reach out to broad range of target groups and market leaders across diverse spectrum of research fields, providing high quality information across USA, Europe, Asia Pacific and ME.

For media queries, write to: contactus@pulsus.com Ph: 650-268-9744
Logo - https://mma.prnewswire.com/media/544592/PULSUS_Logo.jpg

Latest Press Release

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens# FibroScan(R), Imposes Damages Orders Halt to Manufacturing and Sales

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky Medical,...

5 Ways to Set Healthy Grocery Shopping Habits in 2019

By Susan Bowerman, M.S., RD, CSSD, CSOWM, FAN, Senior Director, Worldwide Nutrition Education and Training Make your daily staples as healthy as you can. Small changes in the foods you eat every day can add up to big rewards. The holidays are over, and...

Related Topics